By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
When a person is having a sudden cardiac arrest, an AED, or automated external defibrillator, is used to assist them. It is an advanced yet simple to use medical equipment that can analyse the heart’s rhythm and, if necessary, provide an electrical shock, or defibrillation, to aid in the heart’s re-establishment of an efficient rhythm.
A portable electronic device called an automated external defibrillator (AED) automatically recognises the potentially fatal cardiac rhythms known as ventricular fibrillation and pulseless ventricular tachycardia.
The majority of defibrillators are energy-based, which means that they provide a predetermined number of joules of energy after charging a capacitor to a chosen voltage. The transthoracic impedance and the chosen voltage determine how much energy reaches the heart.
The Global Defibrillator Electronics market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Heart Start FR3 Automated External Defibrillator for Professional Responders Treating Victims of Sudden Cardiac Arrest is Introduced by Royal Philips Electronics For professional responders who care for victims of sudden cardiac arrest (SCA), Royal Philips Electronics (NYSE: PHG, AEX: PHI) today launched the Philips Heart Start FR3 automated external defibrillator (AED) in the United States.
The Heart Start FR3 is Philips’ most sophisticated professional-grade AED and is the smallest and lightest among top global manufacturers. The durable and dependable Heart Start FR3 is intended to assist professional responders save lives more quickly and easily. In order to utilise the FR3 in the United States, a prescription is required, and it must be used under a doctor’s supervision.
Nearly 300,000 people in the US die from SCA each year, making it one of the leading killers. Ventricular fibrillation is the irregular heart rhythm most frequently linked to SCA, and defibrillation is recognised as the sole effective treatment.
Cardiopulmonary resuscitation (CPR) cannot by itself restore a normal heart rhythm, however it can assist extend the window of survival. Few attempts to revive a SCA victim beyond 10 minutes without defibrillation are successful.
A bright, high-resolution, colour LCD that provides visible prompts for easier use in noisy environments, a CPR metronome that maintains the beat for consistent chest compressions, and bilingual configurability so that voice and text prompts can be easily understood by a variety of responders are just a few innovations included in the Heart Start FR3.
